To further elucidate at which stage of G2/M the endometrial cancer cells arrest after GSK3β inhibition, we performed immunofluorescence against phospho-histone H3 (pHH3), a well-established mitotic marker. This evidence concerns the gene GSK3B and endometrial cancer.